A gain-of-function genetic variant in LPL has been reported to be associated with lower fasting insulin and type 2 diabetes risk24, indicating that genetic modulation of lipoprotein lipase activity affects insulin sensitivity and diabetes risk in humans. The gene discussed is LPL; the disease is diabetes mellitus.